261 related articles for article (PubMed ID: 12144816)
1. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
2. Pleomorphic (giant and/or spindle cell) carcinoma of lung shows a high percentage of variant CYP1A12.
Przygodzki RM; Koss MN; O'Leary TJ
Mol Diagn; 2001 Jun; 6(2):109-15. PubMed ID: 11468695
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
4. The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasms.
Heubner M; Wimberger P; Riemann K; Kasimir-Bauer S; Otterbach F; Kimmig R; Siffert W
Oncol Res; 2010; 18(7):343-7. PubMed ID: 20377136
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population.
Aktas D; Hascicek M; Sozen S; Ozen H; Tuncbilek E
Cancer Genet Cytogenet; 2004 Oct; 154(1):81-5. PubMed ID: 15381379
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer.
Tsuchiya Y; Sato T; Kiyohara C; Yoshida K; Ogoshi K; Nakamura K; Yamamoto M
J Exp Clin Cancer Res; 2002 Mar; 21(1):119-24. PubMed ID: 12071517
[TBL] [Abstract][Full Text] [Related]
7. [Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].
He B; Lin J; Cao L; Wang H; Rao J; Liu Y; Zhang Z
Wei Sheng Yan Jiu; 2014 May; 43(3):393-6, 418. PubMed ID: 24964616
[TBL] [Abstract][Full Text] [Related]
8. Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.
Szanyi I; Ráth G; Móricz P; Somogyvári K; Révész P; Gerlinger I; Orsós Z; Ember I; Kiss I
Eur J Cancer Prev; 2012 Nov; 21(6):560-8. PubMed ID: 22273851
[TBL] [Abstract][Full Text] [Related]
9. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma.
Esinler I; Aktas D; Alikasifoglu M; Tuncbilek E; Ayhan A
Int J Gynecol Cancer; 2006; 16(3):1407-11. PubMed ID: 16803538
[TBL] [Abstract][Full Text] [Related]
10. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population.
Öztürk T; Kahraman ÖT; Toptaş B; Kisakesen Hİ; Çakalir C; Verim L; Öztürk O; İsbir T
In Vivo; 2011; 25(4):663-8. PubMed ID: 21709011
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1 polymorphism and risk of gynecological malignancy in Japan.
Sugawara T; Nomura E; Sagawa T; Sakuragi N; Fujimoto S
Int J Gynecol Cancer; 2003; 13(6):785-90. PubMed ID: 14675315
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1 gene polymorphism and polycystic ovary syndrome.
Esinler I; Aktas D; Otegen U; Alikasifoglu M; Yarali H; Tuncbilek E
Reprod Biomed Online; 2008 Mar; 16(3):356-60. PubMed ID: 18339256
[TBL] [Abstract][Full Text] [Related]
13. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
14. [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].
Dai LP; Wang YP; Wu XB; Wang KJ; Lv QJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1198-202. PubMed ID: 20193595
[TBL] [Abstract][Full Text] [Related]
15. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case-control study.
Atinkaya C; Taspinar M; Sakiragaoglu O; Oz G; Yazici U; Oztuna D; Tastepe I; Sunguroglu A
Hum Exp Toxicol; 2012 Oct; 31(10):1074-80. PubMed ID: 22893352
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1 polymorphism in adolescents with polycystic ovary syndrome.
Akgül S; Derman O; Alikaşifoğlu M; Aktaş D
Int J Gynaecol Obstet; 2011 Jan; 112(1):8-10. PubMed ID: 20965504
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia and invasive cervical cancer.
Taskiran C; Aktas D; Yigit-Celik N; Alikasifoglu M; Yuce K; Tunçbilek E; Ayhan A
Gynecol Oncol; 2006 Jun; 101(3):503-6. PubMed ID: 16403567
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1 Ile462Val is a risk factor for ovarian cancer development.
Huang M; Chen Q; Xiao J; Zhao X; Liu C
Cytokine; 2012 Apr; 58(1):73-8. PubMed ID: 22277800
[TBL] [Abstract][Full Text] [Related]
19. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese.
Oyama T; Mitsudomi T; Kawamoto T; Ogami A; Osaki T; Kodama Y; Yasumoto K
Int Arch Occup Environ Health; 1995; 67(4):253-6. PubMed ID: 7591186
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.
Gong FF; Lu SS; Hu CY; Qian ZZ; Feng F; Wu YL; Yang HY; Sun YH
Tumour Biol; 2014 Oct; 35(10):10351-61. PubMed ID: 25048966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
